{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T02:01:34Z","timestamp":1784599294428,"version":"3.55.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":60,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["841319"],"award-info":[{"award-number":["841319"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-73401-9","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T16:35:47Z","timestamp":1779467747000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tumor sialylation regulates G-CSF stability and promotes neutrophil-mediated immunosuppression in breast cancer"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4832-3090","authenticated-orcid":false,"given":"Stefan","family":"Mereiter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6692-8395","authenticated-orcid":false,"given":"Gustav","family":"Jonsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4759-1728","authenticated-orcid":false,"given":"Tiago","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0501-8520","authenticated-orcid":false,"given":"Ingrid-Judith","family":"Garberis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Helm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4626-7731","authenticated-orcid":false,"given":"Markus","family":"Abeln","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6981-1384","authenticated-orcid":false,"given":"Ann-Kristin","family":"Jochum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Jochum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5404-0628","authenticated-orcid":false,"given":"Max J.","family":"Kellner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Feith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Tkalec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Wasilewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7781-5762","authenticated-orcid":false,"given":"Jie","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Emsenhuber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3729-9857","authenticated-orcid":false,"given":"Felix","family":"Holstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9556-5914","authenticated-orcid":false,"given":"Anna C.","family":"Obenauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9334-4405","authenticated-orcid":false,"given":"Guido","family":"Kroemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6641-8536","authenticated-orcid":false,"given":"Magali","family":"Lacroix-Triki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar Hasan","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Flatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5796-368X","authenticated-orcid":false,"given":"Rita","family":"Gerardy-Schahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0991-7627","authenticated-orcid":false,"given":"Anja","family":"M\u00fcnster-K\u00fchnel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5693-6690","authenticated-orcid":false,"given":"Johannes","family":"Stadlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1596-0998","authenticated-orcid":false,"given":"Laurence","family":"Zitvogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef M.","family":"Penninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"73401_CR1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-pathol-042020-042741","volume":"16","author":"S Bagchi","year":"2021","unstructured":"Bagchi, S., Yuan, R. & Engleman, E. G. Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance. Annu. Rev. Pathol. 16, 223\u2013249 (2021).","journal-title":"Annu. Rev. Pathol."},{"key":"73401_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-023-00508-3","volume":"9","author":"V Debien","year":"2023","unstructured":"Debien, V. et al. Immunotherapy in breast cancer: an overview of current strategies and perspectives. NPJ Breast Cancer 9, 7 (2023).","journal-title":"NPJ Breast Cancer"},{"key":"73401_CR3","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1158\/1078-0432.CCR-16-2569","volume":"23","author":"RH Vonderheide","year":"2017","unstructured":"Vonderheide, R. H., Domchek, S. M. & Clark, A. S. Immunotherapy for breast cancer: what are we missing? Clin. Cancer Res. 23, 2640\u20132646 (2017).","journal-title":"Clin. Cancer Res."},{"key":"73401_CR4","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/s41568-024-00714-6","volume":"24","author":"MA Harris","year":"2024","unstructured":"Harris, M. A. et al. Towards targeting the breast cancer immune microenvironment. Nat. Rev. Cancer 24, 554\u2013577 (2024).","journal-title":"Nat. Rev. Cancer"},{"key":"73401_CR5","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41591-024-03415-7","volume":"31","author":"F Cardoso","year":"2025","unstructured":"Cardoso, F. et al. Pembrolizumab and chemotherapy in high-risk, early-stage, ER(+)\/HER2(-) breast cancer: a randomized phase 3 trial. Nat. Med. 31, 442\u2013448 (2025).","journal-title":"Nat. Med."},{"key":"73401_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1056\/NEJMoa2202809","volume":"387","author":"J Cortes","year":"2022","unstructured":"Cortes, J. et al. Pembrolizumab plus chemotherapy in advanced triple-negative breast cancer. N. Engl. J. Med. 387, 217\u2013226 (2022).","journal-title":"N. Engl. J. Med."},{"key":"73401_CR7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ccell.2019.06.006","volume":"36","author":"S Mereiter","year":"2019","unstructured":"Mereiter, S., Balmana, M., Campos, D., Gomes, J. & Reis, C. A. Glycosylation in the era of cancer-targeted therapy: where are we heading? Cancer Cell 36, 6\u201316 (2019).","journal-title":"Cancer Cell"},{"key":"73401_CR8","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.ccell.2024.09.010","volume":"42","author":"C Galassi","year":"2024","unstructured":"Galassi, C., Chan, T. A., Vitale, I. & Galluzzi, L. The hallmarks of cancer immune evasion. Cancer Cell 42, 1825\u20131863 (2024).","journal-title":"Cancer Cell"},{"key":"73401_CR9","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1158\/2326-6066.CIR-22-0366","volume":"10","author":"H Laubli","year":"2022","unstructured":"Laubli, H., Nalle, S. C. & Maslyar, D. Targeting the siglec-sialic acid immune axis in cancer: current and future approaches. Cancer Immunol. Res. 10, 1423\u20131432 (2022).","journal-title":"Cancer Immunol. Res."},{"key":"73401_CR10","first-page":"1","volume":"75","author":"R Schauer","year":"2018","unstructured":"Schauer, R. & Kamerling, J. P. Exploration of the sialic acid world. Adv. Carbohydr. Chem. Biochem. 75, 1\u2013213 (2018).","journal-title":"Adv. Carbohydr. Chem. Biochem."},{"key":"73401_CR11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/128_2013_477","volume":"366","author":"M Sellmeier","year":"2015","unstructured":"Sellmeier, M., Weinhold, B. & Munster-Kuhnel, A. CMP-sialic acid synthetase: the point of constriction in the sialylation pathway. Top. Curr. Chem. 366, 139\u2013167 (2015).","journal-title":"Top. Curr. Chem."},{"key":"73401_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.799861","volume":"12","author":"M Hugonnet","year":"2021","unstructured":"Hugonnet, M., Singh, P., Haas, Q. & von Gunten, S. The distinct roles of sialyltransferases in cancer biology and onco-immunology. Front Immunol. 12, 799861 (2021).","journal-title":"Front Immunol."},{"key":"73401_CR13","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/nsmb1109-1121","volume":"16","author":"JC Paulson","year":"2009","unstructured":"Paulson, J. C. & Rademacher, C. Glycan terminator. Nat. Struct. Mol. Biol. 16, 1121\u20131122 (2009).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"73401_CR14","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abj1270","volume":"14","author":"MA Stanczak","year":"2022","unstructured":"Stanczak, M. A. et al. Targeting cancer glycosylation repolarizes tumor-associated macrophages allowing effective immune checkpoint blockade. Sci. Transl. Med. 14, eabj1270 (2022).","journal-title":"Sci. Transl. Med."},{"key":"73401_CR15","doi-asserted-by":"publisher","first-page":"4912","DOI":"10.1172\/JCI120612","volume":"128","author":"MA Stanczak","year":"2018","unstructured":"Stanczak, M. A. et al. Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells. J. Clin. Invest. 128, 4912\u20134923 (2018).","journal-title":"J. Clin. Invest."},{"key":"73401_CR16","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/annonc\/mdu450","volume":"26","author":"R Salgado","year":"2015","unstructured":"Salgado, R. et al. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. Ann. Oncol. 26, 259\u2013271 (2015).","journal-title":"Ann. Oncol."},{"key":"73401_CR17","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3389\/fgene.2019.00401","volume":"10","author":"Y Zhao","year":"2019","unstructured":"Zhao, Y. et al. Biological characteristics of severe combined immunodeficient mice produced by CRISPR\/Cas9-mediated Rag2 and IL2rg mutation. Front. Genet. 10, 401 (2019).","journal-title":"Front. Genet."},{"key":"73401_CR18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.immuni.2018.11.014","volume":"50","author":"S Kurtulus","year":"2019","unstructured":"Kurtulus, S. et al. Checkpoint blockade immunotherapy induces dynamic changes in PD-1(-)CD8(+) tumor-infiltrating T cells. Immunity 50, 181\u2013194 e186 (2019).","journal-title":"Immunity"},{"key":"73401_CR19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","volume":"50","author":"I Siddiqui","year":"2019","unstructured":"Siddiqui, I. et al. Intratumoral Tcf1(+)PD-1(+)CD8(+) T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy. Immunity 50, 195\u2013211 e110 (2019).","journal-title":"Immunity"},{"key":"73401_CR20","doi-asserted-by":"publisher","unstructured":"Wang, X. Q. et al. Spatial predictors of immunotherapy response in triple-negative breast cancer. Nature https:\/\/doi.org\/10.1038\/s41586-023-06498-3 (2023).","DOI":"10.1038\/s41586-023-06498-3"},{"key":"73401_CR21","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/s41417-021-00389-3","volume":"29","author":"H Zhang","year":"2022","unstructured":"Zhang, H. et al. Oncolytic adenoviruses synergistically enhance anti-PD-L1 and anti-CTLA-4 immunotherapy by modulating the tumour microenvironment in a 4T1 orthotopic mouse model. Cancer Gene Ther. 29, 456\u2013465 (2022).","journal-title":"Cancer Gene Ther."},{"key":"73401_CR22","doi-asserted-by":"publisher","unstructured":"Sebastian, A. et al. Single-cell transcriptomic analysis of tumor-derived fibroblasts and normal tissue-resident fibroblasts reveals fibroblast heterogeneity in breast cancer. Cancers 12 https:\/\/doi.org\/10.3390\/cancers12051307 (2020).","DOI":"10.3390\/cancers12051307"},{"key":"73401_CR23","doi-asserted-by":"publisher","unstructured":"Fabian, K. P., Padget, M. R., Fujii, R., Schlom, J. & Hodge, J. W. Differential combination immunotherapy requirements for inflamed (warm) tumors versus T cell excluded (cool) tumors: engage, expand, enable, and evolve. J. Immunother. Cancer 9 https:\/\/doi.org\/10.1136\/jitc-2020-001691 (2021).","DOI":"10.1136\/jitc-2020-001691"},{"key":"73401_CR24","doi-asserted-by":"publisher","first-page":"772","DOI":"10.4049\/jimmunol.2200154","volume":"209","author":"G Wigerblad","year":"2022","unstructured":"Wigerblad, G. et al. Single-cell analysis reveals the range of transcriptional states of circulating human neutrophils. J. Immunol. 209, 772\u2013782 (2022).","journal-title":"J. Immunol."},{"key":"73401_CR25","first-page":"2019","volume":"21","author":"L Liu","year":"2020","unstructured":"Liu, L., Liu, Y., Yan, X., Zhou, C. & Xiong, X. The role of granulocyte colony\u2011stimulating factor in breast cancer development: a review. Mol. Med. Rep. 21, 2019\u20132029 (2020).","journal-title":"Mol. Med. Rep."},{"key":"73401_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.yexmp.2006.06.007","volume":"82","author":"SA DuPre","year":"2007","unstructured":"DuPre, S. A. & Hunter, K. W. Jr Murine mammary carcinoma 4T1 induces a leukemoid reaction with splenomegaly: association with tumor-derived growth factors. Exp. Mol. Pathol. 82, 12\u201324 (2007).","journal-title":"Exp. Mol. Pathol."},{"key":"73401_CR27","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1016\/j.immuni.2023.11.002","volume":"56","author":"T Taifour","year":"2023","unstructured":"Taifour, T. et al. The tumor-derived cytokine Chi3l1 induces neutrophil extracellular traps that promote T cell exclusion in triple-negative breast cancer. Immunity 56, 2755\u20132772.e2758 (2023).","journal-title":"Immunity"},{"key":"73401_CR28","doi-asserted-by":"publisher","unstructured":"Chafe, S. C. et al. Granulocyte colony stimulating factor expression in breast cancer and its association with carbonic anhydrase IX and immune checkpoints. Cancers 13 https:\/\/doi.org\/10.3390\/cancers13051022 (2021).","DOI":"10.3390\/cancers13051022"},{"key":"73401_CR29","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/febs.14206","volume":"285","author":"KA Mouchemore","year":"2018","unstructured":"Mouchemore, K. A., Anderson, R. L., Hamilton, J. A. & Neutrophils, G. - CSF and their contribution to breast cancer metastasis. FEBS J. 285, 665\u2013679 (2018).","journal-title":"FEBS J."},{"key":"73401_CR30","doi-asserted-by":"publisher","DOI":"10.1126\/science.adf6493","volume":"383","author":"MSF Ng","year":"2024","unstructured":"Ng, M. S. F. et al. Deterministic reprogramming of neutrophils within tumors. Science 383, eadf6493 (2024).","journal-title":"Science"},{"key":"73401_CR31","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41568-020-0281-y","volume":"20","author":"S Jaillon","year":"2020","unstructured":"Jaillon, S. et al. Neutrophil diversity and plasticity in tumour progression and therapy. Nat. Rev. Cancer 20, 485\u2013503 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"73401_CR32","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ijpharm.2005.06.007","volume":"300","author":"G Gregoriadis","year":"2005","unstructured":"Gregoriadis, G., Jain, S., Papaioannou, I. & Laing, P. Improving the therapeutic efficacy of peptides and proteins: a role for polysialic acids. Int. J. Pharm. 300, 125\u2013130 (2005).","journal-title":"Int. J. Pharm."},{"key":"73401_CR33","doi-asserted-by":"publisher","first-page":"4597","DOI":"10.1074\/jbc.M210612200","volume":"278","author":"EI Park","year":"2003","unstructured":"Park, E. I., Manzella, S. M. & Baenziger, J. U. Rapid clearance of sialylated glycoproteins by the asialoglycoprotein receptor. J. Biol. Chem. 278, 4597\u20134602 (2003).","journal-title":"J. Biol. Chem."},{"key":"73401_CR34","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nature24015","volume":"549","author":"J Stadlmann","year":"2017","unstructured":"Stadlmann, J. et al. Comparative glycoproteomics of stem cells identifies new players in ricin toxicity. Nature 549, 538\u2013542 (2017).","journal-title":"Nature"},{"key":"73401_CR35","doi-asserted-by":"publisher","first-page":"35149","DOI":"10.1074\/jbc.M114.606517","volume":"289","author":"MS Macauley","year":"2014","unstructured":"Macauley, M. S. et al. Systemic blockade of sialylation in mice with a global inhibitor of sialyltransferases. J. Biol. Chem. 289, 35149\u201335158 (2014).","journal-title":"J. Biol. Chem."},{"key":"73401_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/2046-2530-3-4","volume":"3","author":"EH Mitchell","year":"2014","unstructured":"Mitchell, E. H. & Serra, R. Normal mammary development and function in mice with Ift88 deleted in MMTV- and K14-Cre expressing cells. Cilia 3, 4 (2014).","journal-title":"Cilia"},{"key":"73401_CR37","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/ncb1530","volume":"9","author":"ML Asselin-Labat","year":"2007","unstructured":"Asselin-Labat, M. L. et al. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat. Cell Biol. 9, 201\u2013209 (2007).","journal-title":"Nat. Cell Biol."},{"key":"73401_CR38","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nature09387","volume":"468","author":"D Schramek","year":"2010","unstructured":"Schramek, D. et al. Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. Nature 468, 98\u2013102 (2010).","journal-title":"Nature"},{"key":"73401_CR39","first-page":"1","volume":"163","author":"A Buque","year":"2021","unstructured":"Buque, A. et al. MPA\/DMBA-driven mammary carcinomas. Methods Cell Biol. 163, 1\u201319 (2021).","journal-title":"Methods Cell Biol."},{"key":"73401_CR40","doi-asserted-by":"publisher","first-page":"64289","DOI":"10.18632\/oncotarget.11733","volume":"7","author":"MC Abba","year":"2016","unstructured":"Abba, M. C. et al. DMBA induced mouse mammary tumors display high incidence of activating Pik3caH1047 and loss of function Pten mutations. Oncotarget 7, 64289\u201364299 (2016).","journal-title":"Oncotarget"},{"key":"73401_CR41","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.dci.2018.05.008","volume":"86","author":"KF Bornhofft","year":"2018","unstructured":"Bornhofft, K. F., Goldammer, T., Rebl, A. & Galuska, S. P. Siglecs: a journey through the evolution of sialic acid-binding immunoglobulin-type lectins. Dev. Comp. Immunol. 86, 219\u2013231 (2018).","journal-title":"Dev. Comp. Immunol."},{"key":"73401_CR42","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1002\/cbic.201700083","volume":"18","author":"M Abeln","year":"2017","unstructured":"Abeln, M. et al. Sialylation is dispensable for early murine embryonic development in vitro. ChemBioChem 18, 1305\u20131316 (2017).","journal-title":"ChemBioChem"},{"key":"73401_CR43","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1681\/ASN.2018090951","volume":"30","author":"KM Niculovic","year":"2019","unstructured":"Niculovic, K. M. et al. Podocyte-specific sialylation-deficient mice serve as a model for human FSGS. J. Am. Soc. Nephrol. 30, 1021\u20131035 (2019).","journal-title":"J. Am. Soc. Nephrol."},{"key":"73401_CR44","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3389\/fonc.2018.00174","volume":"8","author":"ST Teoh","year":"2018","unstructured":"Teoh, S. T., Ogrodzinski, M. P., Ross, C., Hunter, K. W. & Lunt, S. Y. Sialic acid metabolism: a key player in breast cancer metastasis revealed by metabolomics. Front. Oncol. 8, 174 (2018).","journal-title":"Front. Oncol."},{"key":"73401_CR45","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nature19330","volume":"537","author":"SJ Im","year":"2016","unstructured":"Im, S. J. et al. Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy. Nature 537, 417\u2013421 (2016).","journal-title":"Nature"},{"key":"73401_CR46","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","volume":"20","author":"BC Miller","year":"2019","unstructured":"Miller, B. C. et al. Subsets of exhausted CD8(+) T cells differentially mediate tumor control and respond to checkpoint blockade. Nat. Immunol. 20, 326\u2013336 (2019).","journal-title":"Nat. Immunol."},{"key":"73401_CR47","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s41375-023-01808-0","volume":"37","author":"KA Romine","year":"2023","unstructured":"Romine, K. A. et al. BET inhibitors rescue anti-PD1 resistance by enhancing TCF7 accessibility in leukemia-derived terminally exhausted CD8(+) T cells. Leukemia 37, 580\u2013592 (2023).","journal-title":"Leukemia"},{"key":"73401_CR48","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ejca.2022.07.004","volume":"174","author":"J Koh","year":"2022","unstructured":"Koh, J. et al. TCF1(+)PD-1(+) tumour-infiltrating lymphocytes predict a favorable response and prolonged survival after immune checkpoint inhibitor therapy for non-small-cell lung cancer. Eur. J. Cancer 174, 10\u201320 (2022).","journal-title":"Eur. J. Cancer"},{"key":"73401_CR49","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202002566R","volume":"35","author":"J Zhang","year":"2021","unstructured":"Zhang, J., Lyu, T., Cao, Y. & Feng, H. Role of TCF-1 in differentiation, exhaustion, and memory of CD8(+) T cells: a review. FASEB J. 35, e21549 (2021).","journal-title":"FASEB J."},{"key":"73401_CR50","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1016\/j.ccell.2023.08.001","volume":"41","author":"G Escobar","year":"2023","unstructured":"Escobar, G. et al. Tumor immunogenicity dictates reliance on TCF1 in CD8(+) T cells for response to immunotherapy. Cancer Cell 41, 1662\u20131679.e1667 (2023).","journal-title":"Cancer Cell"},{"key":"73401_CR51","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1002\/ijc.32084","volume":"144","author":"LAM Cornelissen","year":"2019","unstructured":"Cornelissen, L. A. M. et al. Disruption of sialic acid metabolism drives tumor growth by augmenting CD8(+) T cell apoptosis. Int. J. Cancer 144, 2290\u20132302 (2019).","journal-title":"Int. J. Cancer"},{"key":"73401_CR52","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1038\/s41589-020-0622-x","volume":"16","author":"MA Gray","year":"2020","unstructured":"Gray, M. A. et al. Targeted glycan degradation potentiates the anticancer immune response in vivo. Nat. Chem. Biol. 16, 1376\u20131384 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"73401_CR53","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41586-019-1456-0","volume":"572","author":"AA Barkal","year":"2019","unstructured":"Barkal, A. A. et al. CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy. Nature 572, 392\u2013396 (2019).","journal-title":"Nature"},{"key":"73401_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1026377","volume":"12","author":"A Theyab","year":"2022","unstructured":"Theyab, A. et al. New insight into strategies used to develop long-acting G-CSF biologics for neutropenia therapy. Front. Oncol. 12, 1026377 (2022).","journal-title":"Front. Oncol."},{"key":"73401_CR55","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1158\/2326-6066.CIR-20-0431","volume":"9","author":"M Kiss","year":"2021","unstructured":"Kiss, M. et al. IL1beta promotes immune suppression in the tumor microenvironment independent of the inflammasome and gasdermin D. Cancer Immunol. Res. 9, 309\u2013323 (2021).","journal-title":"Cancer Immunol. Res."},{"key":"73401_CR56","doi-asserted-by":"publisher","unstructured":"Li, X. et al. MCRS1 sensitizes T cell-dependent immunotherapy by augmenting MHC-I expression in solid tumors. J. Exp. Med. 221 https:\/\/doi.org\/10.1084\/jem.20240959 (2024).","DOI":"10.1084\/jem.20240959"},{"key":"73401_CR57","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41586-020-2229-5","volume":"581","author":"K Yamamoto","year":"2020","unstructured":"Yamamoto, K. et al. Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I. Nature 581, 100\u2013105 (2020).","journal-title":"Nature"},{"key":"73401_CR58","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1158\/2159-8290.CD-23-0584","volume":"14","author":"W Sang","year":"2024","unstructured":"Sang, W. et al. Receptor-interacting protein kinase 2 is an immunotherapy target in pancreatic cancer. Cancer Discov. 14, 326\u2013347 (2024).","journal-title":"Cancer Discov."},{"key":"73401_CR59","doi-asserted-by":"publisher","unstructured":"Silva, Z. et al. MHC class I stability is modulated by cell surface sialylation in human dendritic cells. Pharmaceutics 12 https:\/\/doi.org\/10.3390\/pharmaceutics12030249 (2020).","DOI":"10.3390\/pharmaceutics12030249"},{"key":"73401_CR60","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.3389\/fimmu.2018.01271","volume":"9","author":"A Sacchi","year":"2018","unstructured":"Sacchi, A. et al. Myeloid-derived suppressor cells specifically suppress IFN-gamma production and antitumor cytotoxic activity of Vdelta2 T cells. Front. Immunol. 9, 1271 (2018).","journal-title":"Front. Immunol."},{"key":"73401_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21550-4","volume":"12","author":"E Rodriguez","year":"2021","unstructured":"Rodriguez, E. et al. Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9. Nat. Commun. 12, 1270 (2021).","journal-title":"Nat. Commun."},{"key":"73401_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16596-9","volume":"11","author":"G Boivin","year":"2020","unstructured":"Boivin, G. et al. Durable and controlled depletion of neutrophils in mice. Nat. Commun. 11, 2762 (2020).","journal-title":"Nat. Commun."},{"key":"73401_CR63","doi-asserted-by":"crossref","unstructured":"Hoffmann, D. et al. Identification of lectin receptors for conserved SARS-CoV-2 glycosylation sites. EMBO J. 40, e108375 (2021).","DOI":"10.15252\/embj.2021108375"},{"key":"73401_CR64","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.2915","volume":"8","author":"C Tolg","year":"2018","unstructured":"Tolg, C., Cowman, M. & Turley, E. A. Mouse mammary gland whole mount preparation and analysis. Bio Protoc. 8, e2915 (2018).","journal-title":"Bio Protoc."},{"key":"73401_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2022.101951","volume":"4","author":"L Kalfeist","year":"2023","unstructured":"Kalfeist, L. et al. Simultaneous isolation of CD45 tumor-infiltrating lymphocytes, tumor cells, and associated fibroblasts from murine breast tumor model by MACS. STAR Protoc. 4, 101951 (2023).","journal-title":"STAR Protoc."},{"key":"73401_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14049","volume":"8","author":"GX Zheng","year":"2017","unstructured":"Zheng, G. X. et al. Massively parallel digital transcriptional profiling of single cells. Nat. Commun. 8, 14049 (2017).","journal-title":"Nat. Commun."},{"key":"73401_CR67","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587 e3529 (2021).","journal-title":"Cell"},{"key":"73401_CR68","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411\u2013420 (2018).","journal-title":"Nat. Biotechnol."},{"key":"73401_CR69","doi-asserted-by":"publisher","unstructured":"Bartha, A. & Gyorffy, B. TNMplot.com: a web tool for the comparison of gene expression in normal, tumor and metastatic tissues. Int. J. Mol. Sci. 22, https:\/\/doi.org\/10.3390\/ijms22052622 (2021).","DOI":"10.3390\/ijms22052622"},{"key":"73401_CR70","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang, Z., Kang, B., Li, C., Chen, T. & Zhang, Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 47, W556\u2013W560 (2019).","journal-title":"Nucleic Acids Res."},{"key":"73401_CR71","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li, T. et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 48, W509\u2013W514 (2020).","journal-title":"Nucleic Acids Res."},{"key":"73401_CR72","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.chroma.2003.10.029","volume":"1023","author":"L Jiang","year":"2004","unstructured":"Jiang, L., He, L. & Fountoulakis, M. Comparison of protein precipitation methods for sample preparation prior to proteomic analysis. J. Chromatogr. A 1023, 317\u2013320 (2004).","journal-title":"J. Chromatogr. A"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73401-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73401-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73401-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T01:03:10Z","timestamp":1784595790000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73401-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["73401"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-73401-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"28 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"6760"}}